Trends in drugs usage for COVID-19 during the first wave of the pandemic in a hospital in Lima, Peru
DOI:
https://doi.org/10.17843/rpmesp.2021.384.8820Keywords:
COVID-19, Pneumonia, Therapeutics, Drugs Utilization, Hospitalization, Epidemiologic Factors, Anti-bacterial Agents, Dexamethasone, Peru, TrendsAbstract
This study aimed to evaluate the pharmacological trends in patients with COVID-19 from a hospital in Peru during the first wave of the pandemic. Retrospective study conducted between April and September 2020. The medical records of patients hospitalized for COVID-19 pneumonia at the Dos de Mayo National
Hospital (Lima, Peru) were reviewed. Of a total of 3103 patients, 381 medical records were included (77.4% male, median age: 44 years). The use of four prehospital drugs increased (azithromycin, ivermectin, corticosteroids, and ceftriaxone), while the in-hospital use of six drugs (ceftriaxone, azithromycin,
hydroxychloroquine, ivermectin, corticosteroid pulse, and prophylactic anticoagulation) decreased and in-hospital anticoagulation use decreased. These findings suggest that the management of COVID-19 has varied during the first wave of the pandemic, typically increasing prehospital drug use and decreasing
inpatient use.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Revista Peruana de Medicina Experimental y Salud Pública
This work is licensed under a Creative Commons Attribution 4.0 International License.